{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:43:06Z","timestamp":1770219786689,"version":"3.49.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T00:00:00Z","timestamp":1403654400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0100882","type":"journal-article","created":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T20:29:42Z","timestamp":1403728182000},"page":"e100882","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["Dose Responsive Effects of Subcutaneous Pentosan Polysulfate Injection in Mucopolysaccharidosis Type VI Rats and Comparison to Oral Treatment"],"prefix":"10.1371","volume":"9","author":[{"given":"Michael","family":"Frohbergh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanli","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nesrin","family":"Karabul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Solyom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alon","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Iatridis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward H.","family":"Schuchman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calogera M.","family":"Simonaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,6,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the mucopolysaccharidoses","volume":"50","author":"J Muenzer","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3233\/PRM-2010-0100","article-title":"Evaluation of disease severity in mucopolysaccharidoses","volume":"3","author":"M Beck","year":"2010","journal-title":"J Pediatr Rehabil Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.rdc.2013.03.004","article-title":"Mucopolysaccharidoses and other lysosomal storage diseases","volume":"39","author":"C Lampe","year":"2013","journal-title":"Rheum Dis Clin North Am"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1590\/S1415-47572010005000093","article-title":"Mucopolysaccharidosis I, II, and VI: Brief review and guidelines for treatment","volume":"33","author":"R Giugliani","year":"2010","journal-title":"Genet Mol Biol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/8904_2011_56","article-title":"Combined enzyme replacement therapy and hematopoietic stem cell transplantation in mucopolysacharidosis type VI","volume":"2","author":"D Sillence","year":"2012","journal-title":"JIMD Rep"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/peds.2007-3847","article-title":"Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I","volume":"123","author":"LA Clarke","year":"2009","journal-title":"Pediatrics"},{"key":"ref7","article-title":"Current and potential therapeutic strategies for mucopolysaccharidoses","author":"H Noh","year":"2014","journal-title":"J Clin Pharm Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"v26","DOI":"10.1093\/rheumatology\/ker393","article-title":"Orthopaedic aspects of mucopolysaccharidoses","volume":"50","author":"KK White","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"ref9","first-page":"26","article-title":"Enzyme replacement therapy for lysosomal storage diseases","volume":"10","author":"T Ohashi","year":"2012","journal-title":"Pediatr Endocrinol Rev"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1750-1172-8-155","article-title":"Treatment of hip dysplasia in patients with mucopolysaccharidosis type I after hematopoietic stem cell transplantation: results of an international consensus procedure","volume":"8","author":"EJ Langereis","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054459","article-title":"Pentosan polysulfate: a novel therapy for the mucopolysaccharidoses","volume":"8","author":"EH Schuchman","year":"2013","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1073\/pnas.0912937107","article-title":"Involvement of the Toll-like receptor 4 pathway and use of TNF-alpha antagonists for treatment of the mucopolysaccharidoses","volume":"107","author":"CM Simonaro","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1203\/01.PDR.0000156510.96253.5A","article-title":"Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models","volume":"57","author":"CM Simonaro","year":"2005","journal-title":"Pediatr Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/labinvest.3780345","article-title":"Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: a possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses","volume":"81","author":"CM Simonaro","year":"2001","journal-title":"Lab Invest"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0049-0172(99)80021-3","article-title":"The pathobiology of osteoarthritis and the rationale for the use of pentosan polysulfate for its treatment","volume":"28","author":"P Ghosh","year":"1999","journal-title":"Semin Arthritis Rheum"},{"key":"ref16","first-page":"927","article-title":"Antithrombotic therapy in patients with known risk factors for thromboembolism","volume":"116","author":"H Vinazzer","year":"1989","journal-title":"Folia Haematol Int Mag Klin Morphol Blutforsch"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archsurg.1976.01360190039006","article-title":"Drug prevention of postoperative deep vein thrombosis. A compararative study of calcium heparinate and sodium pentosan polysulfate","volume":"111","author":"S Joffe","year":"1976","journal-title":"Arch Surg"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00192-010-1252-8","article-title":"Treatment choice, duration, and cost in patients with interstitial cystitis and painful bladder syndrome","volume":"22","author":"JT Anger","year":"2011","journal-title":"Int Urogynecol J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.juro.2011.03.064","article-title":"AUA guideline for the diagnosis and treatment of interstitial cystitis\/bladder pain syndrome","volume":"185","author":"PM Hanno","year":"2011","journal-title":"J Urol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1751-0813.2012.00959.x","article-title":"Effects of intra-articular sodium pentosan polysulfate and glucosamine on the cytology, total protein concentration and viscosity of synovial fluid in horses","volume":"90","author":"C Kwan","year":"2012","journal-title":"Aust Vet J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2460\/ajvr.73.5.628","article-title":"Evaluation of intramuscularly administered sodium pentosan polysulfate for treatment of experimentally induced osteoarthritis in horses","volume":"73","author":"CW McIlwraith","year":"2012","journal-title":"Am J Vet Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"S Reagan-Shaw","year":"2008","journal-title":"Faseb Journal"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1006\/geno.1995.9962","article-title":"Mucopolysaccharidosis type VI in rats: isolation of cDNAs encoding arylsulfatase B, chromosomal localization of the gene, and identification of the mutation","volume":"29","author":"T Kunieda","year":"1995","journal-title":"Genomics"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.archoralbio.2003.12.007","article-title":"Absolute and relative growth of the rat craniofacial skeleton","volume":"49","author":"JR VandeBerg","year":"2004","journal-title":"Arch Oral Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jocd.2013.03.004","article-title":"Low bone mineral content and challenges in interpretation of dual-energy X-ray absorptiometry in children with mucopolysaccharidosis types I, II, and VI","volume":"17","author":"LE Polgreen","year":"2014","journal-title":"J Clin Densitom"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"9889","DOI":"10.1016\/S0021-9258(17)36966-1","article-title":"Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors\/binding proteins","volume":"269","author":"SD Yan","year":"1994","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/art.30290","article-title":"S100A8 enhances osteoclastic bone resorption in vitro through activation of Toll-like receptor 4: implications for bone destruction in murine antigen-induced arthritis","volume":"63","author":"LC Grevers","year":"2011","journal-title":"Arthritis Rheum"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/art.33495","article-title":"Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4","volume":"64","author":"RF Schelbergen","year":"2012","journal-title":"Arthritis Rheum"},{"key":"ref29","first-page":"243","article-title":"Levels of chemerin and interleukin 8 in the synovial fluid of patients with inflammatory arthritides and osteoarthritis","volume":"32","author":"E Valcamonica","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1136\/ard.2007.077800","article-title":"Myeloid-related proteins S100A8\/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis","volume":"67","author":"PL van Lent","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"v49","DOI":"10.1093\/rheumatology\/ker396","article-title":"Therapy for the mucopolysaccharidoses","volume":"50","author":"V Valayannopoulos","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"ref32","first-page":"45","article-title":"Current and emerging management options for patients with Morquio A syndrome","volume":"9","author":"MF Algahim","year":"2013","journal-title":"Ther Clin Risk Manag"},{"key":"ref33","article-title":"Postmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate","author":"PK Newman","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/pr.2013.158","article-title":"Immune response to intrathecal enzyme replacement therapy in mucopolysaccharidosis I patients","volume":"74","author":"M Vera","year":"2013","journal-title":"Pediatr Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10545-013-9613-3","article-title":"Mucopolysaccharide diseases: a complex interplay between neuroinflammation, microglial activation and adaptive immunity","volume":"37","author":"LD Archer","year":"2014","journal-title":"J Inherit Metab Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0100882","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T09:07:46Z","timestamp":1649495266000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0100882"}},"subtitle":[],"editor":[{"given":"Raphael","family":"Schiffmann","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,25]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0100882","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,25]]}}}